Acceleron Pharma
XLRN
#1542
Rank
NZ$18.14 B
Marketcap
$296.65
Share price
0.00%
Change (1 day)
14,733.42%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$18.14 Billion

As of April 2025 Acceleron Pharma has a market cap of NZ$18.14 Billion. This makes Acceleron Pharma the world's 1542th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$247.42 B 1,263.80%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$102.17 B 463.21%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$629.78 B 3,371.39%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$34.69 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.27 B-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$67.26 M-99.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$208.38 B 1,048.65%๐Ÿ‡บ๐Ÿ‡ธ USA